Although the original Phase 3 A4 trial showed no statistically significant overall benefit for solanezumab (a humanized monoclonal antibody designed to treat Alzheimer’s disease by binding to and ...

DAREONTM-9, a phase Ib study of obrixtamig plus topotecan in patients (pts) with advanced small cell lung cancer (SCLC): Interim analysis results. Comprehensive longitudinal immune cell monitoring in ...

Unfortunately, this book can't be printed from the OpenBook. Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.

Subgroup analysis in clinical trials constitutes a vital methodological tool to uncover differential treatment effects within specified categories of patients. This approach enables researchers to ...

Secondary analysis of the RESOLVE trial suggests the benefits of graded sensorimotor retraining across patient groups with chronic low back pain.

ROC curves illustrating the discriminative ability of the VR-specific 30-day mortality prediction models. (A–C) Performance of the high VR model in the ARDSnet training cohort (A), internal validation ...

Germline determinants of pneumonitis in patients with cancer treated with antibody drug conjugates. Impact of health literacy in cancer outpatients receiving oral anticancer drugs and followed by the ...